The depression-executive dysfunction (DED) syndrome and response to antidepressants: A meta-analytic review

International Journal of Geriatric Psychiatry

Volumn 25, Issue 10, 2010, Pages 933-944

  McLennan, Skye N ^a   Mathias, Jane L ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

antidepressants; cognition; depression; executive function; neuropsychological tests; prefrontal cortex

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEPRESSION; DEPRESSION EXECUTIVE DYSFUNCTION; DISEASE MODEL; DRUG TREATMENT FAILURE; ELECTROCONVULSIVE THERAPY; HUMAN; MEDLINE; META ANALYSIS; PSYCINFO; REVIEW; SCREENING; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL;

EID: 78649442024     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2431     Document Type: Review

References (53)

1. Alexopoulos G, Meyers BS, Young RC, et al,. 1997. 'Vascular depression' hypothesis. Arch Gen Psychiaty 54: 915-922.
2. Alexopoulos GS,. 2001. The depression-executive dysfunction syndrome of late life: a specific target for D3 agonists? Am J Geriatr Psychiatry 9: 22-29.
3. Alexopoulos GS, Kiosses DN, Heo M, et al,. 2005. Executive dysfunction and the course of geriatric depression. Biol Psychiatry 58: 204-210.
4. Alexopoulos GS, Kiosses DN, Klimstra S, Kalayam B, Bruce ML,. 2002. Clinical presentation of the 'depression-executive dysfunction syndrome' of late life. Am J Geriatr Psychiatry 10: 98-106.
5. Alexopoulos GS, Kiosses DN, Murphy C, Heo M,. 2004. Executive dysfunction, heart disease burden, and remission of geriatric depression. Neuropsychopharmacology 29: 2278-2284.
6. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al,. 2007. Event-related potentials in an emotional go/no-go task and remission of geriatric depression. Neuroreport 18: 217-221.
7. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al,. 2008. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 165: 238-244.
8. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington, DC.
9. Bogner HR, Bruce ML, Reynolds CF III, et al,. the Prospect Group. 2007. The effects of memory, attention, and executive dysfunction on outcomes of depression in a primary care intervention trial: the PROSPECT study. Int J Geriatr Psychiatry 22: 922-929.
10. Caligiuri MP, Gentili V, Eberson S, et al,. 2003. A quantitative neuromotor predictor of antidepressant non-response in patients with major depression. J Affect Disord 77: 135-141.
11. Cohen J,. 1992. A power primer. Psychol Bull. 112: 155-159.
12. de Groot MH, Nolen WA, Huijsman AM, Bouvy PF,. 1996. Lateralized neuropsychological functioning in depressive patients before and after drug therapy. Biol Psychiatry 40: 1282-1287.
13. Deuschle M, Kniest A, Niemann H, et al,. 2004. Impaired declarative memory in depressed patients is slow to recover: clinical experience. Pharmacopsychiatry 37: 147-151.
14. Devanand DP, Pelton GH, Marston K, et al,. 2003. Sertraline treatment of elderly patients with depression and cognitive impairment. Int J Geriatr Psychiatry 18: 123-130.
15. Doraiswamy PM, Krishnan KRR, Oxman T, et al,. 2003. Does antidepressant therapy improve cognition in elderly depressed patients? J Gerontol A Biol Sci Med Sci 58: M1137-1144.
16. Dunkin JJ, Leuchter AF, Cook IA, et al,. 2000. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord 60: 13-23.
17. Gallagher P, Robinson LJ, Gray JM, Porter RJ, Young AH,. 2007. Neurocognitive function following remission in major depressive disorder: potential objective marker of response? Aust N Z J Public Health 41: 54-61.
18. Garcia-Toro M, Talavera JA, Gonzalez E, et al,. 2003. Audioverbal cognitive dysfunction in depression. Factors involved. Prog Neuropsychopharmacol Biol Psychiatry 27: 37-42.
19. Herrmann LL, Le Masurier M, Ebmeier KP,. 2008. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry 79: 619-624.
20. Hickie I, Scott E, Mitchell P, et al,. 1995. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37: 151-160.
21. Howland RH, Wilson MG, Kornstein SG, et al,. 2008. Factors predicting reduced antidepressant response: experience with the SNRI Duloxetine in patients with major depression. Ann Clin Psychiatry 20: 209-218.
22. Jurica PJ, Leitten CL, Mattis S,. 2001. Dementia Rating Scale-2: Professional Manual. Psychological Assessment Resources: Lutz.
23. Kalayam B, Alexopoulos GS,. 1999. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 56: 713-718. (Pubitemid 29357732)
24. Kalayam B, Alexopoulos GS,. 2003. A preliminary study of left frontal region error negativity and symptom improvement in geriatric depression. Am J Psychiatry 160: 2054-2056.
25. Kampf-Sherf O, Zlotogorski Z, Gilboa A, et al,. 2004. Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants. J Affect Disord 82: 453-459.
26. Lezak MD, Howieson DB, Loring DW,. 2004. Neuropsychological Assessment. Oxford University Press: New York.
27. Lipsey MW, Wilson DB,. 2001. Practical Meta-analysis. Sage: Thousand Oaks.
28. Lyness JM, Caine ED, King DA, et al,. 2002. Depressive disorders and symptoms in older primary care patients: one-year outcomes. Am J Geriatr Psychiatry 10: 275-282.
29. Majer M, Ising M, Kunzel H, et al,. 2004. Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychol Med 34: 1453-1463.
30. Marcos T, Portella MJ, Navarro V, et al,. 2005. Neuropsychological prediction of recovery in late-onset major depression. Int J Geriatr Psychiatry 20: 790-795.
31. Mayberg HS,. 1997. Limbic-Cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 9: 471-481.
32. Mayberg HS, Brannan SK, Mahurin RK, et al,. 1997. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8: 1057-1061.
33. Mayberg HS, Brannan SK, Tekell JL, et al,. 2000. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 48: 830-843.
34. National Collaborating Centre For Mental Health. 2007. Depression (amended) management of depression in primary and secondary care. NICE Clinical Guideline 23. National Institute for Health and Clinical Excellence (NICE): London.
35. Nemeroff CB,. 2002. Recent advances in the neurobiology of depression. Psychopharmacol Bul 36: 6-23.
36. Portella MJ, Marcos T, Rami L, et al,. 2003. Residual cognitive impairment in late-life depression after a 12-month period follow-up. Int J Geriatr Psychiatry 18: 571-576.
37. Potter GG, Kittinger JD, Wagner HR, Steffens DC, Krishnan KR,. 2004a. Prefrontal neuropsychological predictors of treatment remission in late-life depression. Neuropsychopharmacology 29: 2266-2271.
38. Potter GG, Kittinger JD, Wagner HR, Steffens DC, Krishnan RR,. 2004b. Prefrontal neuropsychological predictors of treatment remission in late-life depression. Neuropsychopharmacology 29: 2266-2271.
39. Robinson RG, Kubos KL, Starr LK, Al E,. 1984. Mood disorders in stroke patients: importance of location of lesions. Brain 107: 81-93.
40. Saghafi R, Brown C, Butters MA, et al,. 2007. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatry 22: 1141-1146.
41. Simpson S, Baldwin RC, Jackson A, Burns AS,. 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 28: 1015-1026.
42. Sneed JR, Keilp JG, Brickman AM, Roose SP,. (2008a) The specificity of neuropsychological impairment in predicting antidepressant non-response in the very old depressed. Int J Geriatr Psychiatry 23: 319-323.
43. Sneed JR, Roose SP, Keilp JG, et al,. 2007. Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry 15: 545-552.
44. Sneed JR, Rutherford BR, Rindskopf D, et al,. 2008b. Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. Am J Geriatr Psychiatry 16: 65-73.
45. Stahl SM, Zhang L, Damatarca C, Grady M,. 2003. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J Clin Psychiatry 64: 6-17.
46. Story TJ, Potter GG, Attix DK, Welsh-Bohmer KA, Steffens DC,. 2008. Neurocognitive correlates of response to treatment in late-life depression. Am J Geriatr Psychiatry 16: 752-759.
47. Stoudemire A, Hill CD, Morris R, et al,. 1991. Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly. Am J Psychiatry 148: 1336-1340.
48. Taylor BP, Bruder GE, Stewart JW, et al,. 2006. Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients. Am J Psychiatry 163: 73-78.
49. Taylor WD, Steffens DC, Macfall JR, et al,. 2003. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 60: 1090-1096.
50. Tekin S, Cummings JL,. 2002. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 53: 647-654.
51. Veiel HOF,. 1997. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol 19: 587-603.
52. Williams JWJ, Mulrow CD, Chiquette E, et al,. 2000. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 132: 743-756.
53. Zakzanis KK,. 2001. Statistics to tell the truth, the whole truth, and nothing but the truth: formulae, illustrative numerical examples, and heuristic interpretation of effect size analysis for neuropsychological researchers. Arch Clin Neuropsychol 16: 653-667.